Innovation leads to safer, smarter drugs and real-world support tools
By avoiding established pharmacological treatments that may produce significant side effects, parents try to alleviate behavioral problems and associated comorbid conditions using alternative treatments
HUBERMAN: Why certain ones may be advantageous for certain purposes, of course, also highlighting the potential risks and in some case, outright dangers
The product is not intended to diagnose, treat, cure, or prevent any disease and should only be handled by qualified professionals operating within controlled scientific environments
FDA Pharmacy Compounding Advisory Committee recommends the inclusion of six peptide substances, including BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax, on the FDA's 503A Bulks List, representing a significant step in the FDA's ongoing regulatory review process for these peptide substances
09.03.24 September MDL numbers increased The MDL numbers published on September 3, 2024, showed that hundreds of plaintiffs filed lawsuits against GLP-1 RA drug manufacturers
